← Research library

Epithalamin and 15-year follow-up in older adults with coronary disease

Comparison in people · 2011

What was studied
79 older patients with coronary disease. Thirty-nine received adjunctive Epithalamin and 40 received standard care alone.
Main finding
At 15 years, 26/39 patients in the Epithalamin group and 16/40 in the standard-care group were alive. This small historical comparison followed patients with coronary disease.

Alive at 15 years · 26/39 (66.7%) vs 16/40 (40.0%) · Epithalamin plus standard care versus standard care.

Reported findings and study design

Reported randomized comparative follow-up from the Kyiv gerontology program with survival curves and cardiovascular outcomes.

Population or model 79 older patients with coronary disease. Thirty-nine received adjunctive Epithalamin and 40 received standard care alone.

Dose, route and schedule

10 mg in 2 mL saline intramuscularly every third morning, five injections per course (50 mg per course). Six courses at six-month intervals over the first three years, with basic therapy. The 15-year result is follow-up after that treatment period.

Protocol source ↗ · Original English paper and indexed Russian-program publications. Compared with an earlier 12-year report and a Palermo conference citation.

Results · Original English paper and indexed Russian-program publications. Compared with an earlier 12-year report and a Palermo conference citation.
MeasureResultComparison, timing and statistics
Alive at 15 years26/39 (66.7%) vs 16/40 (40.0%)Epithalamin plus standard care versus standard care.
Deaths attributed to myocardial infarction or stroke6/13 deaths vs 20/24 deathsCause-of-death counts among participants who died.

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • Small historical comparison, with limited reporting about masking and subsequent treatment. The associated 12-year paper may share the same participants.
  • Epithalamin is a pineal extract. The study did not administer synthetic Epitalon.

Related publications may describe some of the same participants or experiments.

Source details

Original English paper and indexed Russian-program publications. Compared with an earlier 12-year report and a Palermo conference citation.

Sources checked

Citation

Human comparative studyFull text available

O. V. Korkushko, V. Kh. Khavinson, V. B. Shatilo, I. A. Antoniuk-Shcheglova. Epithalamin and 15-year follow-up in older adults with coronary disease Bulletin of Experimental Biology and Medicine. 2011;151(3):366–369. PMID 22451889.

Study source ↗ · DOI 10.1007/s10517-011-1332-x · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards